author-photo

Gregory Di Russo

Pfizer

4

Papers

12

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Updated Results of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (PF-07055480/SB-525) Gene Therapy in Adults with Severe Hemophilia a

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Updated Follow-up of the Alta Study, a Phase 1/2, Open Label, Adaptive, Dose-Ranging Study to Assess the Safety and Tolerability of SB-525 Gene Therapy in Adult Patients with Severe Hemophilia A

2019 Blood
Show All
- Source
- Cite
- Save
Citations (8)
The renal elimination of apixaban: the totality of data relating to the renal clearance of apixaban in patients with impaired renal function: response to Hellfritzsch et al.

2017 Pharmacoepidemiology and Drug Safety
Show All
- Source
- Cite
- Save
Citations (0)